Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor [EARLY_Phase 1]
Early-phase trial of TP53 R248Q-targeted TCR-T cell therapy for advanced solid tumors is not yet recruiting. The trial lists lung adenocarci…
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors [Phase 1]
Phase 1 study of LY3300054, an anti-PD-L1 antibody, given alone or in combination in adults with advanced refractory solid tumors, including…
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway [Phase 1]
This clinical trial update describes a Phase 1 study of the PARP inhibitor DAT-2645 monotherapy for advanced/metastatic solid tumors harbori…
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Quality of Life of Patients Over 75 Yars Undergoing Palliative Chemotherapy
The update notes a terminated clinical trial evaluating quality of life in patients over 75 undergoing palliative chemotherapy for several g…
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 bioequivalence study comparing the proposed talazoparib capsule formulation to the current formulation, plus a food-effect assessmen…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Progression-free Survival After MWA Plus Durvalumab and Tremelimumab for Unresectable Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating progression-free survival in patients with unresectable, locally advanced pancreatic cancer treated with m…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: EUS FNB Versus FNA With On-Site Cytopathology in Solid Pancreatic Masses [NA]
A clinical trial comparing EUS-guided Fine Needle Biopsy (FNB) versus Fine Needle Aspiration (FNA) with on-site cytopathology for solid panc…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Prevalence and Consequences of Hyperlactemia Following Pancreatic Surgery
A completed clinical trial report examining how common hyperlactatemia is after pancreatic surgery and the associated consequences.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Evaluation of Survival Prognostic Factors for Patients With Exocrine Pancreatic Cancer Resectable or Potentially Resectable [NA]
A completed clinical trial update evaluating survival prognostic factors in patients with resectable or potentially resectable exocrine panc…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Multidimensional Prehabilitation in Pancreatic Surgery for Pancreatic and Periampullary Neoplasms [NA]
A completed clinical trial evaluating multidimensional prehabilitation in pancreatic surgery for pancreatic and periampullary neoplasms.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: New Onset Diabetes Management for Earlier Detection of Pancreatic Cancer (NODMED) [NA]
Terminated clinical trial (NODMED) evaluating whether managing new-onset diabetes can enable earlier detection of pancreatic cancer; no resu…
-
CLINICAL_TRIALS trial_result · 2024-09-04Clinical Trial Update: CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma [Phase 1, Phase 2]
A Phase 1/2 trial of CEND-1 Injection (QLC12102) in advanced metastatic pancreatic ductal adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: Phase 2 Study of S-1 as 2nd Line Therapy in Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 study evaluating S-1 as second-line therapy for metastatic pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-28Clinical Trial Update: CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic Cancer [Phase 1]
This clinical trial update reports the Phase 1 study of CEND-1 in combination with nab-paclitaxel and gemcitabine for metastatic pancreatic …
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: QUILT-3.080: NANT Pancreatic Cancer Vaccine [Phase 1, Phase 2]
Clinical trial update for QUILT-3.080 (NANT Pancreatic Cancer Vaccine) in pancreatic cancer; the Phase 1/2 study by ImmunityBio has been ter…
-
CLINICAL_TRIALS trial_result · 2024-08-26Clinical Trial Update: Oral Protein Supplements for Nutritional and Quality of Life Improvement After Pancreatic Resection in Elderly Patients [NA]
A completed clinical trial from Yonsei University evaluated whether oral protein supplements improve nutrition and quality of life after pan…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Lidocaine Infusion With ERAS Protocol for Pancreatic Cancer Surgery: Effect on Pain and Patient Immunity. [NA]
A completed clinical trial evaluating lidocaine infusion within an ERAS protocol for pancreatic cancer surgery and its effects on postoperat…
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: Effects of Red Ginseng on Gastrointestinal Symptoms and Microbiota After Surgery for Gastrointestinal Cancer [NA]
A completed clinical trial evaluating the effects of red ginseng on postoperative gastrointestinal symptoms and gut microbiota in cancer pat…
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors [Phase 1, Phase 2]
This update reports the termination of a Phase 1/2 trial of AMG 655 in combination with AMG 479 for advanced, refractory solid tumors, with …
-
CLINICAL_TRIALS trial_result · 2024-08-16Clinical Trial Update: A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Advanced Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial studying Fluzoparib in combination with mFOLFIRINOX in advanced pancreatic cancer has completed Phase 1/2 enrollment.
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: A Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002) [Phase 2]
Phase 2 study MK-2140-002 evaluating Zilovertamab vedotin (VLS-101) in solid tumors including triple-negative breast cancer and non-small-ce…
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the Pancreas [Phase 2]
Phase 2 trial evaluating GVAX pancreatic tumor cell vaccine with cyclophosphamide, SBRT, and the FOLFIRINOX regimen in patients with resecte…
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer [Phase 2]
Phase 2 trial update for a vitamin C plus G-FLIP regimen (low-dose gemcitabine, 5-FU, leucovorin, irinotecan, oxaliplatin) in pancreatic can…
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: The Effect of Albumin Value, HALP Score, and LCR Value on Predicting Survival and Recurrence in Patients With Pancreatic Adenocarcinoma
A completed clinical trial update examining whether albumin levels, HALP score, and LCR value can predict survival and recurrence in pancrea…
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer [EARLY_Phase 1]
Early-phase trial evaluating pharmacogenomics-guided use of supportive care medications in patients with advanced cancers; the study has com…